Intellectual-property decisions involving pharmaceutical materials depend on evidence that can withstand scientific and legal scrutiny. Triclinic Labs supports counsel, innovator and generic pharmaceutical companies, chemistry, manufacturing, and controls (CMC) teams, and retained experts with controlled laboratory studies, data review, solid-form assessment, prior-art reproduction, comparative testing, and witness support.
Our scientists determine what material was made or tested, how it was characterized, what the evidence supports, and where scientific uncertainty remains. Counsel remains responsible for legal advice, strategy, and argument.
These services support counsel, CMC teams, formulation scientists, and technical experts who need analytical or experimental evidence for patent, ANDA, prior-art, lifecycle, or witness questions. Triclinic provides scientific work plans, testing, data interpretation, and technical reports; counsel remains responsible for legal advice, strategy, and argument.
Experimental design, comparative testing, data review, prior-art reproduction, and expert-witness support for Hatch-Waxman and Paragraph IV Abbreviated New Drug Application (ANDA) technical questions, including scientific issues relevant to validity or infringement opinions.
Controlled execution of cited procedures, documented treatment of ambiguous variables, and analytical characterization of the materials actually produced.
Pre-litigation and pre-ANDA assessment of polymorph, salt, cocrystal, hydrate, solvate, amorphous-material, amorphous-dispersion, and formulation coverage to identify scientific support, vulnerabilities, and gaps.
Clearly scoped expert-witness or fact-witness support for disputes involving pharmaceutical materials, analytical methods, solid-state chemistry, laboratory records, and technical evidence.
| If the central question is… | Start with… |
|---|---|
| Does the patent portfolio adequately cover relevant solid forms, and where are the scientific gaps? | Solid-State Patent Strength Assessment |
| What does a cited patent or publication procedure actually produce? | Reproduction of Prior Art |
| What scientific evidence is needed for a Paragraph IV or ANDA dispute? | Paragraph IV ANDA Expert Support |
| Is scientific opinion, testimony, or firsthand laboratory evidence needed? | Expert Witness and Fact Witness Support |
Some matters require more than one path. A patent-strength assessment may identify prior-art experiments, comparative testing, or expert support needed for the next decision.
Start with the decision that must be supported. Use patent-strength assessment to evaluate portfolio coverage and scientific gaps; prior-art reproduction to determine what a cited procedure produces; Paragraph IV ANDA support for product, claim, or technical disputes; and witness support when scientific opinion, testimony, or firsthand laboratory evidence is needed.
Yes. Triclinic can evaluate whether the available work adequately addresses polymorphs, salts, cocrystals, hydrates, solvates, amorphous materials, amorphous dispersions, formulations, and other relevant solid forms. The assessment identifies scientific strengths, vulnerabilities, and gaps before litigation or a potential generic ANDA.
Yes. Triclinic can support counsel, technical teams, and retained experts with scientific analysis, experimental design, material characterization, comparative testing, prior-art reproduction, data review, and witness support.
Yes. When scoped to the scientific question and intended evidentiary use, experimental work can support patent prosecution, portfolio assessment, diligence, partnering, lifecycle planning, Paragraph IV matters, or litigation. Triclinic provides scientific evidence and technical interpretation; counsel determines its legal use.
Yes, when the cited procedure, materials, assumptions, and reasonable experimental variables can be defined. The work documents ambiguities, agreed assumptions, deviations, observations, analytical results, and the limits of the resulting conclusions.
An expert witness may analyze evidence and offer qualified scientific opinions within the expert’s field. A fact witness testifies about work performed, observations made, records created, or other firsthand knowledge. The role, scope, reporting requirements, communications, and testimony expectations should be defined before work begins.
Yes. When retained as expert witnesses, Triclinic scientists may offer opinions on patent validity or infringement based on their scientific expertise, technical analysis, and the evidence in the matter. These expert opinions are not legal determinations. The court ultimately determines whether a patent is valid or infringed, while counsel remains responsible for legal strategy and argument.
Documentation can include approved work plans, sample provenance and custody, method conditions, raw and processed data, processing parameters, reference materials, figures, observations, deviations, limitations, alternative explanations, and technical interpretation tied to the question being evaluated.
Share the patent, prior-art, ANDA, product-comparison, or expert-support question, along with available samples, procedures, data, and timing. We'll perform a conflict check before discussions are initiated.
